Sep 10, 2010
2nd Circuit Upsets Class Certification for Third-Party Payers in Zyprexa Case
A federal appeals court has rejected class certification for third-party payers who claim Eli Lilly misrepresented the drug Zyprexa’s effectiveness and safety.